Rajakaruna Chanaka, Rogers Chris A, Suranimala Chinthaki, Angelini Gianni D, Ascione Raimondo
Bristol Heart Institute, Bristol Royal Infirmary, Bristol, United Kingdom.
J Thorac Cardiovasc Surg. 2006 Oct;132(4):802-10. doi: 10.1016/j.jtcvs.2006.05.056.
Surgical case-mix is seriously worsening, and the results of surgical revascularization on high-risk cohorts should be continuously evaluated. This study investigates the influence of diabetes mellitus on the short and midterm outcome in the modern era of coronary surgery.
Patients who underwent first-time coronary artery bypass grafting from April 1996 to October 2003 were classified into diabetic and nondiabetic groups. Data were prospectively collected and retrospectively analyzed. A total of 5259 patients were studied, and of these 877 (17%) were diabetic. Patients with diabetes were more likely to be female, have a higher body mass index, be in an advanced New York Heart Association class and Canadian Cardiovascular Society class, have a history of congestive heart failure, have a poor ejection fraction, renal failure, and more extensive coronary artery disease than the nondiabetic group (P < .001 for all). In-hospital mortality was 2.2% and 1% for diabetic and nondiabetic patients, respectively; however, diabetes was not found to be an independent risk factor for in-hospital mortality (odds ratio = 1.63; 95% confidence interval 0.92-2.88; P = .089). Postoperative complications were comparable in the two groups, with only renal, neurologic, and gastrointestinal complications significantly associated with diabetes (all P < or = .05). There was no association between diabetes mellitus and postoperative infective complications. Diabetes remained an independent predictor of 5-year mortality (hazard ratio 1.55; 95% confidence interval 1.22-1.96; P < .001) and of lower 5-year cardiac-related event-free survival.
Despite a worsening cohort, diabetic patients could be surgically revascularized with low morbidity and mortality, comparable with control patients. The negative effect of diabetes mellitus on the longer-term mortality and morbidity remains a problem.
外科病例组合情况正在严重恶化,应持续评估高危人群外科血管重建术的效果。本研究调查了糖尿病对当代冠状动脉手术短期和中期结果的影响。
将1996年4月至2003年10月期间首次接受冠状动脉旁路移植术的患者分为糖尿病组和非糖尿病组。前瞻性收集数据并进行回顾性分析。共研究了5259例患者,其中877例(17%)为糖尿病患者。与非糖尿病组相比,糖尿病患者更可能为女性,体重指数更高,纽约心脏协会心功能分级和加拿大心血管学会分级更高,有充血性心力衰竭病史,射血分数低,有肾衰竭,且冠状动脉疾病更广泛(所有P<0.001)。糖尿病患者和非糖尿病患者的住院死亡率分别为2.2%和1%;然而,未发现糖尿病是住院死亡率的独立危险因素(比值比=1.63;95%置信区间0.92-2.88;P=0.089)。两组术后并发症相当,只有肾脏、神经和胃肠道并发症与糖尿病显著相关(所有P≤0.05)。糖尿病与术后感染性并发症之间无关联。糖尿病仍然是5年死亡率(风险比1.55;95%置信区间1.22-1.96;P<0.001)和较低的5年无心脏相关事件生存率的独立预测因素。
尽管病例组合情况恶化,但糖尿病患者仍可接受外科血管重建术,其发病率和死亡率较低,与对照组患者相当。糖尿病对长期死亡率和发病率的负面影响仍然是一个问题。